PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor ( IC 50 =0.016 μM; K i =5.9 nM). PLX5622 allows for extended and specific microglial cells elimination , preceding and during pathology development. PLX5622 demonstrates desirable PK properties in varies animals . PLX5622 is predominantly administered via ad libitum diets with a dose of 1200 ppm.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > c-Fms
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.